Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann-Lii Cheng

Showing results (1-10 of 490) with videos related to

Pageof 49
Sort By:
Nature Reviews. Gastroenterology & Hepatology|January 7, 2021
Pursuing efficacious systemic therapy for hepatocellular carcinomaAnn-Lii Cheng
Hematology. American Society of Hematology. Education Program|December 10, 2013
Helicobacter pylori and mucosa-associated lymphoid tissue: what's newSung-Hsin Kuo, Ann-Lii Cheng
Advances in Experimental Medicine and Biology|June 16, 2007
Clinical studies with curcuminChih-Hung Hsu, Ann-Lii Cheng
The New England Journal of Medicine|August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. ReplyRichard S Finn, Ann-Lii Cheng
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2004
Recent advances in therapy for gastric cancerKun-Huei Yeh, Ann-Lii Cheng
Journal of Hepatology|October 29, 2017
Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma"Jordi Bruix, Ann Lii Cheng, Josep Llovet
Hepatology (Baltimore, Md.)|December 7, 2013
Reply: To PMID 24002804Chiun Hsu, Pei-Jer Chen, Ann-Lii Cheng
Journal of Gastroenterology|June 23, 2010
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectivesYing-Chun Shen, Chiun Hsu, Ann-Lii Cheng
Annals of Internal Medicine|July 22, 2009
Lamivudine and hepatitis B reactivationChiun Hsu, Ann-Lii Cheng, Pei-Jer Chen
Expert Review of Clinical Pharmacology|January 14, 2014
Sorafenib for the treatment of hepatocellular carcinoma across geographic regionsChiun Hsu, Ying-Chun Shen, Ann Lii Cheng
Pageof 49

Showing results (1-10 of 490) with videos related to

Sort By:
Pageof 49
Nature Reviews. Gastroenterology & Hepatology|January 7, 2021
Pursuing efficacious systemic therapy for hepatocellular carcinomaAnn-Lii Cheng
Hematology. American Society of Hematology. Education Program|December 10, 2013
Helicobacter pylori and mucosa-associated lymphoid tissue: what's newSung-Hsin Kuo, Ann-Lii Cheng
Advances in Experimental Medicine and Biology|June 16, 2007
Clinical studies with curcuminChih-Hung Hsu, Ann-Lii Cheng
The New England Journal of Medicine|August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma. ReplyRichard S Finn, Ann-Lii Cheng
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 5, 2004
Recent advances in therapy for gastric cancerKun-Huei Yeh, Ann-Lii Cheng
Journal of Hepatology|October 29, 2017
Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma"Jordi Bruix, Ann Lii Cheng, Josep Llovet
Hepatology (Baltimore, Md.)|December 7, 2013
Reply: To PMID 24002804Chiun Hsu, Pei-Jer Chen, Ann-Lii Cheng
Journal of Gastroenterology|June 23, 2010
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectivesYing-Chun Shen, Chiun Hsu, Ann-Lii Cheng
Annals of Internal Medicine|July 22, 2009
Lamivudine and hepatitis B reactivationChiun Hsu, Ann-Lii Cheng, Pei-Jer Chen
Expert Review of Clinical Pharmacology|January 14, 2014
Sorafenib for the treatment of hepatocellular carcinoma across geographic regionsChiun Hsu, Ying-Chun Shen, Ann Lii Cheng
Pageof 49